Table 2.
Unadjusted |
Adjusted* |
||||||
---|---|---|---|---|---|---|---|
Variable | Sample size | Slope estimate | 95% Confidence interval | p Value | Slope estimate | 95% Confidence interval | p Value |
Continuous proximal cluster of differentiation (CD4) count | |||||||
Proximal CD4 < 500, per 50 | 234 | −0.16 | −0.28 to −0.04 | 0.008 | −0.16 | −0.28 to −0.04 | 0.011 |
Proximal CD4 ≥ 500, per 50 Continuous nadir CD4 count | 0.05 | −0.08 to 0.18 | 0.444 | 0.07 | −0.06 to 0.20 | 0.306 | |
Continuous nadir CD4 count | |||||||
Nadir CD4 < 250, per 50 | 251 | −0.38 | −0.63 to −0.14 | 0.002 | −0.39 | −0.64 to −0.14 | 0.004 |
Nadir CD4 ≥ 250, per 50 | 0.13 | −0.02 to 0.28 | 0.096 | 0.14 | −0.01 to 0.30 | 0.069 | |
Proximal CD4 count < 200 cells/mm | 234 | 0.66 | −0.09 to 1.41 | 0.0845 | 0.59 | −0.20 to 1.38 | 0.140 |
CD4 Nadir < 200 cells/mm3 | 251 | 0.42 | −0.34 to 1.18 | 0.275 | 0.37 | −0.40 to 1.15 | 0.344 |
Plasma HIV ribonucleic acid (RNA) < 400 consistently for 6 months or more prior to echo | 219 | −0.70 | −1.48 to 0.08 | 0.077 | −0.76 | −1.60 to 0.08 | 0.076 |
Log10 (Viremia copy years), per 1 | 20 | −0.17 | −0.86 to 0.53 | 0.622 | −0.07 | −0.92 to 0.78 | 0.855 |
Years of known untreated Viremia | 70 | −0.07 | −0.22 to 0.09 | 0.376 | −0.08 | −0.25 to 0.09 | 0.348 |
Adjusted for age, black race, hypertension, hyperlipidemia and diabetes.